Jefferies Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,900
Closed -$5.68M 1886
2025
Q4
$5.68M Hold
55,900
0.03% 460
2025
Q3
$3.06M Sell
55,900
-3,200
-5% -$160K 0.01% 505
2025
Q2
$3.14M Sell
59,100
-23,800
-29% -$1.21M 0.03% 416
2025
Q1
$3.59M Sell
82,900
-6,600
-7% -$334K 0.03% 393
2024
Q4
$5.03M Sell
89,500
-48,200
-35% -$3M 0.03% 362
2024
Q3
$9.38M Hold
137,700
0.07% 183
2024
Q2
$5.82M Buy
137,700
+30,000
+28% +$1.65M 0.06% 251
2024
Q1
$7.44M Sell
107,700
-15,900
-13% -$1.01M 0.07% 211
2023
Q4
$9.14M Sell
123,600
-90,400
-42% -$5.93M 0.06% 244
2023
Q3
$14.6M Sell
214,000
-58,000
-21% -$4.92M 0.13% 115
2023
Q2
$25.5M Buy
272,000
+70,500
+35% +$5.5M 0.23% 78
2023
Q1
$13.7M Buy
201,500
+24,300
+14% +$1.56M 0.11% 155
2022
Q4
$8.77M Buy
+177,200
New +$7.24M 0.06% 240

Other funds holding EXAS

Jefferies Financial Group's EXAS Position: Q1 2026 in Review

Jefferies Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 57,816 shares — an estimated $5.87M sold.

Jefferies Financial Group first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $6.59M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Jefferies Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 57,816 Exact Sciences shares in Q1 2026, an estimated $5.87M.
  • Jefferies Financial Group first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Jefferies Financial Group's Exact Sciences position peaked at $6.59M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.